Oseltamivir Phosphate Capsule
FDA Label NDC 70771-1712

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Oseltamivir Phosphate (NDC 70771-1712). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

NDC 70771-1710-2

OSELTAMIVIR PHOSPHATE Capsules, USP

30* mg

*Each capsule contains oseltamivir phosphate equivalent to 30 mg oseltamivir (free base).

10 Capsules

(1 x 10 Unit-Dose)

Rx only

30 mg Label (2dab1ae2 Efaa 4429 8567 01e5b02de77c 01)

NDC 70771-1711-2

OSELTAMIVIR PHOSPHATE Capsules, USP

45* mg

*Each capsule contains oseltamivir phosphate equivalent to 45 mg oseltamivir (free base).

10 Capsules

(1 x 10 Unit-Dose)

Rx only

45 mg Label (2dab1ae2 Efaa 4429 8567 01e5b02de77c 02)

NDC 70771-1712-2

OSELTAMIVIR PHOSPHATE Capsules, USP

75* mg

*Each capsule contains oseltamivir phosphate equivalent to 75 mg oseltamivir (free base).

10 Capsules

(1 x 10 Unit-Dose)

Rx only

75 mg Label (2dab1ae2 Efaa 4429 8567 01e5b02de77c 03)

* Please review the disclaimer below.